Cargando…
Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: Inherent potential for biosynthetic versus live recombinant microbicides
BACKGROUND: Herpes Simplex virus types 1 and 2 are enveloped viruses with a linear dsDNA genome of ~120–200 kb. Genital infection with HSV-2 has been denoted as a major risk factor for acquisition and transmission of HIV-1. Developing biomedical strategies for HSV-2 prevention is thus a central stra...
Autores principales: | Wayengera, Misaki, Kajumbula, Henry, Byarugaba, Wilson |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526989/ https://www.ncbi.nlm.nih.gov/pubmed/18687114 http://dx.doi.org/10.1186/1742-4682-5-18 |
Ejemplares similares
-
Harnessing Pharmacogenomics to Tackle Resistance to the “Nucleoside Reverse Trancripatse Inhibitor” Backbone of Highly Active Antiretroviral Therapy in Resource Limited Settings
por: Wayengera, Misaki, et al.
Publicado: (2008) -
In silico evidence for the species-specific conservation of mosquito retroposons: implications as a molecular biomarker
por: Byarugaba, Wilson, et al.
Publicado: (2009) -
Targeting wild-type Erythrocyte receptors for Plasmodium falciparum and vivax Merozoites by Zinc Finger Nucleases In- silico: Towards a Genetic Vaccine against Malaria
por: Kajumbula, Henry, et al.
Publicado: (2012) -
Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors
por: Wayengera, Misaki
Publicado: (2011) -
Restriction endonuclease AgeI is a monomer which dimerizes to cleave DNA
por: Tamulaitiene, Giedre, et al.
Publicado: (2017)